Arch Biopartners Inc. (ACHFF)
OTCMKTS
· Delayed Price · Currency is USD
1.340
+0.020 (1.51%)
Jun 5, 2025, 3:49 PM EDT
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $87.85 million as of June 6, 2025. Its market cap has decreased by -19.21% in one year.
Market Cap
87.85M
Enterprise Value
89.50M
Revenue
-168.92K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.34
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.63M to 87.85M, an increase of 161.27%. That is a compound annual growth rate of 6.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Veradigm | 730.27M |
| Nika Pharmaceuticals | 666.65M |
| Tian'an Technology Group | 614.49M |
| Elite Pharmaceuticals | 597.81M |
| CytoDyn | 433.92M |
| Glass House Brands | 430.39M |
| Northwest Biotherapeutics | 383.88M |